Is daclatasvir still available?

No, daclatasvir has been [discontinued](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=206843) and is no longer available in the United States.

Why was daclatasvir discontinued?

The manufacturer (Bristol Myers Squibb) voluntarily discontinued daclatasvir for [business reasons](https://medicinespatentpool.org/news-publications-post/affordable-versions-of-hepatitis-c-medicine-daclatasvir-soon-available-in-additional-countries). This medication wasn't taken off the market for safety concerns or lack of benefit.

What other medications can I use instead of daclatasvir?

There are many [different factors](https://www.hcvguidelines.org/) that a provider must consider in choosing the right hepatitis C medication for you, such as your medical history, age, [genotype](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094507/) of the hepatitis C virus, and if you have any liver problems. Several alternative medications are available, including [Epclusa (sofosbuvir / velpatasvir)](https://www.goodrx.com/epclusa/what-is) and [Mavyret (glecaprevir / pibrentasvir)](https://www.goodrx.com/mavyret/what-is), which are typically taken by mouth daily for 8 to 12 weeks. Keep in mind that these medications can cure [95%](https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.31060) of people with hepatitis C. These medications can also help slow down liver damage due to the infection. Talk with your provider to determine which hepatitis C treatment is best for you.

Daklinza

Q: What is daclatasvir?

Daclatasvir is an antiviral medication used for the treatment of hepatitis C infection genotype 1 and 3. It works by attaching to NS5A, an important protein that helps the hepatitis C virus make more copies of itself. Once daclatasvir attaches to this specific protein of the virus, the medication stops the virus from growing. It's often used with [Sovaldi (sofosbuvir)](https://www.goodrx.com/sovaldi/what-is) and sometimes with [ribavirin (Rebetol)](https://www.goodrx.com/ribavirin/what-is) to help remove hepatitis C viruses from the body.

daclatasvir

Used for Hepatitis C

Daclatasvir is a medication that's taken by mouth to treat hepatitis C infection. It's typically used once daily for 12 weeks. It has been discontinued by the manufacturer and is no longer available in the United States.

Reviewed by:

Ally Tsai, PharmD

Kristianne Hannemann, PharmD

Last reviewed on July 5, 2022

What is Daclatasvir?

What is Daclatasvir used for?

Chronic (long-term) hepatitis C infection genotype 1 or 3

Drug facts

Common Brands	Daklinza(brand no longer available)
Drug Class	Antiviral
Controlled Substance Classification	Not a controlled medication
Generic Status	No lower-cost generic available
Availability	Discontinued

Common Brands

Daklinza(brand no longer available)

Drug Class

Antiviral

Controlled Substance Classification

Not a controlled medication

Generic Status

No lower-cost generic available

Availability

Discontinued

Common questions about Daklinza

Daklinza is an antiviral medication used for the treatment of hepatitis C infection genotype 1 and 3. It works by attaching to NS5A, an important protein that helps the hepatitis C virus make more copies of itself. Once Daklinza attaches to this specific protein of the virus, the medication stops the virus from growing. It's often used with Sovaldi (sofosbuvir) and sometimes with ribavirin (Rebetol) to help remove hepatitis C viruses from the body.

No, Daklinza has been discontinued and is no longer available in the United States.

The manufacturer (Bristol Myers Squibb) voluntarily discontinued Daklinza for business reasons. This medication wasn't taken off the market for safety concerns or lack of benefit.

There are many different factors that a provider must consider in choosing the right hepatitis C medication for you, such as your medical history, age, genotype of the hepatitis C virus, and if you have any liver problems. Several alternative medications are available, including Epclusa (sofosbuvir / velpatasvir) and Mavyret (glecaprevir / pibrentasvir), which are typically taken by mouth daily for 8 to 12 weeks. Keep in mind that these medications can cure 95% of people with hepatitis C. These medications can also help slow down liver damage due to the infection. Talk with your provider to determine which hepatitis C treatment is best for you.

Daclatasvir dosage

Typical dosage for Daclatasvir

What are alternatives to Daclatasvir?

There are a number of medications that your doctor can prescribe in place of Daclatasvir. Compare a few possible alternatives below.

Daclatasvir

Used for:

Chronic (long-term) hepatitis C infection genotype 1 or 3

View prices

Mavyret (glecaprevir / pibrentasvir)

Used for:

Acute or chronic hepatitis C genotype 1, 2, 3, 4, 5, or 6 infection in people ages 3 years and older
Hepatitis C genotype 1 infection in people age 3 years and older who were previously treated with an NS5A inhibitor or an HCV protease inhibitor (not both)

$7,609.80Lowest GoodRx priceView prices

Epclusa (sofosbuvir / velpatasvir)

Used for:

Chronic hepatitis C infection

$7,766.04Lowest GoodRx priceView prices

What is Daclatasvir?

What is Daclatasvir used for?

Drug facts

Common questions about Daklinza

What is Daklinza?

Is Daklinza still available?

Why was Daklinza discontinued?

What other medications can I use instead of Daklinza?

Daclatasvir dosage

Typical dosage for Daclatasvir

What are alternatives to Daclatasvir?

Common questions about Daklinza

What is Daklinza?

Is Daklinza still available?

Why was Daklinza discontinued?

What other medications can I use instead of Daklinza?